Human CREB3L2 Protein

Description

Human CREB3L2 Protein
Catalog number: B2012023
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 20 µg
Molecular Weight or Concentration: 250 µg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20 °C
Keywords: cAMP responsive element binding protein 3-like 2 protein, BBF2H7 protein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Oh-Hashi K, Yamamoto A, Murase R, Hirata Y. Comparative Analysis of CREB3 and CREB3L2 Protein Expression in HEK293 Cells Int J Mol Sci. 2021 Mar 9;22(5):2767.
2: Li YH, Tardif G, Hum D, Kapoor M, Fahmi H, Pelletier JP, Martel-Pelletier J. The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target Arthritis Res Ther. 2016 Jul 19;18:172.
3: Panagopoulos I, Monsef N, Collin A, Mertens F. Characterization of an alternative transcript of the human CREB3L2 gene Oncol Rep. 2010 Nov;24(5):1133-9.
4: Panagopoulos I, Mertens F. Characterization of the human CREB3L2 gene promoter Oncol Rep. 2009 Mar;21(3):615-24.
5: Pellegrin S, Haydn-Smith KL, Hampton-O’Neil LA, Hawley BR, Heesom KJ, Fermo E, Bianchi P, Toye AM. Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII Br J Haematol. 2019 Mar;184(5):876-881.
6: Lui WO, Zeng L, Rehrmann V, Deshpande S, Tretiakova M, Kaplan EL, Leibiger I, Leibiger B, Enberg U, Höög A, Larsson C, Kroll TG. CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis Cancer Res. 2008 Sep 1;68(17):7156-64.
7: Panagopoulos I, Möller E, Dahlén A, Isaksson M, Mandahl N, Vlamis-Gardikas A, Mertens F. Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera Genes Chromosomes Cancer. 2007 Feb;46(2):181-91.
8: Möller E, Hornick JL, Magnusson L, Veerla S, Domanski HA, Mertens F. FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1 Clin Cancer Res. 2011 May 1;17(9):2646-56.
9: Tsuda Y, Dickson BC, Dry SM, Federman N, Suurmeijer AJH, Swanson D, Sung YS, Zhang L, Healey JH, Antonescu CR. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature Genes Chromosomes Cancer. 2020 Apr;59(4):217-224.
10: Kondo Y, Fu J, Wang H, Hoover C, McDaniel JM, Steet R, Patra D, Song J, Pollard L, Cathey S, Yago T, Wiley G, Macwana S, Guthridge J, McGee S, Li S, Griffin C, Furukawa K, James JA, Ruan C, McEver RP, Wierenga KJ, Gaffney PM, Xia L. Site-1 protease deficiency causes human skeletal dysplasia due to defective inter-organelle protein trafficking JCI Insight. 2018 Jul 26;3(14):e121596.

Products Related to Human CREB3L2 Protein can be found at Proteins